Data

Click on Protocol Number of interest to view study-related documentation or download data files. (DTMC data files are under development.)
Division Study Number Title Sort descending Investigator(s) Release Date
DTMC NIDA-CPU-0006 A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine Reese Jones, M.D. May 23, 2017
CTN NIDA-CTN-0052 A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC) T. John Winhusen, Ph.D. May 14, 2014
CTN NIDA-CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) Madhukar H. Trivedi, M.D. Oct 07, 2022
CTN NIDA-CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT) Walter Ling, M.D. Oct 09, 2020
CTN NIDA-CTN-0031A An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers T. John Winhusen, Ph.D., Eugene Somoza, M.D. Nov 26, 2013
DTMC NIDA-MDS-0002 Assessment of Interactions Between Methamphetamine and Aripiprazole Thomas F. Newton, M.D. May 07, 2018
DTMC NIDA-CPU-0010 Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine Louis Cantilena, Jr., M.D, Ph.D. Jun 03, 2020
DTMC NIDA-CTO-0003 Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone Thomas F. Newton, M.D. Aug 01, 2016
DTMC NIDA-CTO-0004 Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline Thomas F. Newton, M.D. Aug 01, 2016
DTMC NIDA-CTO-0010 Assessment of Potential Interactions Between Methamphetamine and Bupropion Thomas F. Newton, M.D. May 07, 2018